Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Smart Knee Implant to Evaluate Efficacy of Liposomal Bupivacaine and Bupivacaine With Meloxicam in Early TKA Recovery
NCT07878507Phase 4Not yet recruiting
- Sponsor
- Foundation for Orthopaedic Research and Education
- Start
- Oct 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of bupivacaine and bupivacaine + meloxicam in postoperative pain (3 arms), sponsored by Foundation for Orthopaedic Research and Education. Primary endpoint: Early Functional Recovery at 3 days. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
bupivacainebupivacaine + meloxicam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07878507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07878507.